NYSE:CHE Chemed (CHE) Stock Price, News & Analysis → Shocking $16T Elon Musk Crypto Leak (From Crypto 101 Media) (Ad) Free CHE Stock Alerts $554.84 -3.28 (-0.59%) (As of 05/23/2024 ET) Add Compare Share Share Today's Range$553.34▼$560.6150-Day Range$554.84▼$650.7052-Week Range$492.84▼$654.62Volume53,318 shsAverage Volume80,156 shsMarket Capitalization$8.40 billionP/E Ratio29.86Dividend Yield0.29%Price Target$673.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Get Chemed alerts: Email Address Chemed MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside21.4% Upside$673.50 Price TargetShort InterestHealthy2.01% of Float Sold ShortDividend StrengthStrongBased on Four FactorsSustainability-0.33Upright™ Environmental ScoreNews Sentiment0.61Based on 15 Articles This WeekInsider TradingSelling Shares$12.45 M Sold Last QuarterProj. Earnings Growth10.41%From $21.72 to $23.98 Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.4.94 out of 5 starsMedical Sector18th out of 915 stocksHome Health Care Services Industry1st out of 7 stocks 2.5 Analyst's Opinion Consensus RatingChemed has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageChemed has only been the subject of 2 research reports in the past 90 days.Read more about Chemed's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted2.01% of the float of Chemed has been sold short.Short Interest Ratio / Days to CoverChemed has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Chemed has recently decreased by 31.97%, indicating that investor sentiment is improving significantly. Previous Next 3.3 Dividend Strength Dividend YieldChemed has a dividend yield of 0.29%, which is in the bottom 25% of all stocks that pay dividends.Dividend GrowthChemed has been increasing its dividend for 15 years.Dividend CoverageThe dividend payout ratio of Chemed is 8.61%. This payout ratio is at a healthy, sustainable level, below 75%.Dividend SustainabilityBased on earnings estimates, Chemed will have a dividend payout ratio of 6.67% next year. This indicates that Chemed will be able to sustain or increase its dividend.Read more about Chemed's dividend. Previous Next 4.9 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreChemed has received a 80.32% net impact score from Upright. Chemed seems to create the most significant positive value in categories "Taxes", "Jobs", and "Meaning & joy". The positive contribution in the "Meaning & joy" impact category is mostly driven by its "Private hospice care", "Private home care for the elderly", and "Property water damage restoration" products. See details.Environmental SustainabilityThe Environmental Impact score for Chemed is -0.33. Previous Next 3.1 News and Social Media Coverage News SentimentChemed has a news sentiment score of 0.61. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.45 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for Chemed this week, compared to 5 articles on an average week.Search InterestOnly 1 people have searched for CHE on MarketBeat in the last 30 days. This is a decrease of -80% compared to the previous 30 days.MarketBeat Follows3 people have added Chemed to their MarketBeat watchlist in the last 30 days. Previous Next 2.5 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Chemed insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $12,454,691.00 in company stock.Percentage Held by InsidersOnly 3.32% of the stock of Chemed is held by insiders.Percentage Held by Institutions95.85% of the stock of Chemed is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Chemed's insider trading history. Previous Next 2.5 Earnings and Valuation Earnings GrowthEarnings for Chemed are expected to grow by 10.41% in the coming year, from $21.72 to $23.98 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Chemed is 29.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 147.33.Price to Earnings Ratio vs. SectorThe P/E ratio of Chemed is 29.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 181.54.Price to Earnings Growth RatioChemed has a PEG Ratio of 2.29. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioChemed has a P/B Ratio of 7.10. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about Chemed's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad True Market InsidersThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeThe man who bought Bitcoin and Ethereum in 2017… and has spotted 44 different coins that have returned over 100%... Is now exposing a 10-cent coin that just partnered with Amazon…Click For My #1 FREE Crypto for 2024 About Chemed Stock (NYSE:CHE)Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees. The company was incorporated in 1970 and is headquartered in Cincinnati, Ohio.Read More CHE Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CHE Stock News HeadlinesMay 18, 2024 | insidertrades.comInsider Selling: Chemed Co. (NYSE:CHE) CEO Sells 4,000 Shares of StockMay 22 at 4:34 AM | americanbankingnews.comRoyal Bank of Canada Trims Chemed (NYSE:CHE) Target Price to $697.00May 21 at 3:53 PM | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Hookipa Pharma (HOOK), Chemed (CHE)May 20, 2024 | seekingalpha.comChemed: Growth Does Not Justify The Current Stock PriceMay 20, 2024 | businesswire.comChemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly DividendMay 19, 2024 | americanbankingnews.comKevin J. Mcnamara Sells 4,000 Shares of Chemed Co. (NYSE:CHE) StockMay 17, 2024 | finance.yahoo.comChemed Corp (CHE) CEO Kevin Mcnamara Sells 4,000 SharesMay 7, 2024 | businesswire.comChemed Corporation to Present at the Bank of America Securities Health Care Conference 2024April 30, 2024 | finance.yahoo.comChemed Corporation (NYSE:CHE) Q1 2024 Earnings Call TranscriptApril 29, 2024 | finance.yahoo.comChemed First Quarter 2024 Earnings: EPS Misses ExpectationsApril 27, 2024 | seekingalpha.comChemed Corporation (CHE) Q1 2024 Earnings Call TranscriptApril 27, 2024 | nasdaq.comChemed Corp Breaks Below 200-Day Moving Average - Notable for CHEApril 26, 2024 | finance.yahoo.comChemed Reports 'Soft' Q1 as Roto-Rooter Continues to Face Pressure, Oppenheimer SaysApril 26, 2024 | finance.yahoo.comChemed Corp (CHE) Q1 2024 Earnings Call Transcript Highlights: Diverse Performance Across ...April 26, 2024 | finance.yahoo.comChemed Corporation Just Missed EPS By 14%: Here's What Analysts Think Will Happen NextApril 26, 2024 | finance.yahoo.comQ1 2024 Chemed Corp Earnings CallApril 25, 2024 | msn.comCHE Stock Earnings: Chemed Misses EPS, Misses Revenue for Q1 2024April 24, 2024 | markets.businessinsider.comChemed Corp. Announces Increase In Q1 Income, but misses estimatesApril 24, 2024 | sfgate.comChemed: Q1 Earnings SnapshotApril 24, 2024 | businesswire.comChemed Reports First-Quarter 2024 ResultsApril 23, 2024 | msn.comChemed 2024 Earnings PreviewApril 23, 2024 | markets.businessinsider.comChemed earnings: here's what Wall Street expectsApril 17, 2024 | finance.yahoo.comVITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and AlabamaApril 17, 2024 | businesswire.comVITAS Completes the Previously Announced Purchase of Assets of Covenant in Florida and AlabamaApril 9, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Chemed (CHE) and Alkermes (ALKS)See More Headlines Receive CHE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Chemed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 3/15 Dividend2/23/2024Dividend Payable3/15/2024Last Earnings4/24/2024Today5/24/2024Ex-Dividend for 6/18 Dividend5/30/2024Dividend Payable6/18/2024Next Earnings (Estimated)7/24/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Home health care services Sub-IndustryHealth Care Services Current SymbolNYSE:CHE CUSIP16359R10 CIK19584 Webwww.chemed.com Phone(513) 762-6690Fax513-762-6590Employees15,087Year Founded1970Price Target and Rating Average Stock Price Target$673.50 High Stock Price Target$697.00 Low Stock Price Target$650.00 Potential Upside/Downside+21.4%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage2 Analysts Profitability EPS (Most Recent Fiscal Year)$18.58 Trailing P/E Ratio29.86 Forward P/E Ratio25.55 P/E Growth2.29Net Income$272.51 million Net Margins12.36% Pretax Margin15.86% Return on Equity30.52% Return on Assets20.13% Debt Debt-to-Equity RatioN/A Current Ratio1.91 Quick Ratio1.88 Sales & Book Value Annual Sales$2.26 billion Price / Sales3.71 Cash Flow$24.35 per share Price / Cash Flow22.79 Book Value$78.17 per share Price / Book7.10Miscellaneous Outstanding Shares15,140,000Free Float14,636,000Market Cap$8.40 billion OptionableOptionable Beta0.46 Social Links The Best High-Yield Dividend Stocks for 2024Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.Get This Free Report Key ExecutivesMr. Kevin J. McNamara (Age 70)CEO, President & Director Comp: $5.84MMr. Michael D. Witzeman CPA (Age 53)MBA, VP, Controller, Principal Accounting Officer & CFO Comp: $1.15MMr. Spencer S. Lee (Age 68)Executive Vice President Comp: $1.65MMr. Thomas C. Hutton (Age 73)VP & Director Mr. Nicholas Michael Westfall (Age 45)Executive Vice President Comp: $2.5MMs. Lisa A. ReinhardVP, Chief Administrative Officer & SecretarySherri WarnerDirector of Investor RelationsMr. Brian C. Judkins (Age 43)VP, Secretary & Chief Legal Officer More ExecutivesKey CompetitorsAmedisysNASDAQ:AMEDOption Care HealthNASDAQ:OPCHEncompass HealthNYSE:EHCBio-Rad LaboratoriesNYSE:BIOElanco Animal HealthNYSE:ELANView All CompetitorsInsiders & InstitutionsSecond Line Capital LLCBought 242 shares on 5/22/2024Ownership: 0.024%Burney Co.Sold 80 shares on 5/22/2024Ownership: 0.002%Atria Investments IncSold 285 shares on 5/21/2024Ownership: 0.025%LRI Investments LLCBought 267 shares on 5/21/2024Ownership: 0.002%Tidal Investments LLCSold 64 shares on 5/17/2024Ownership: 0.012%View All Insider TransactionsView All Institutional Transactions CHE Stock Analysis - Frequently Asked Questions Should I buy or sell Chemed stock right now? 2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Chemed in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CHE shares. View CHE analyst ratings or view top-rated stocks. What is Chemed's stock price target for 2024? 2 brokers have issued 12 month price targets for Chemed's stock. Their CHE share price targets range from $650.00 to $697.00. On average, they predict the company's stock price to reach $673.50 in the next year. This suggests a possible upside of 21.4% from the stock's current price. View analysts price targets for CHE or view top-rated stocks among Wall Street analysts. How have CHE shares performed in 2024? Chemed's stock was trading at $584.75 on January 1st, 2024. Since then, CHE stock has decreased by 5.1% and is now trading at $554.84. View the best growth stocks for 2024 here. Are investors shorting Chemed? Chemed saw a decrease in short interest in April. As of April 30th, there was short interest totaling 297,100 shares, a decrease of 32.0% from the April 15th total of 436,700 shares. Based on an average daily trading volume, of 84,700 shares, the short-interest ratio is currently 3.5 days. Approximately 2.0% of the company's shares are short sold. View Chemed's Short Interest. When is Chemed's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Wednesday, July 24th 2024. View our CHE earnings forecast. How were Chemed's earnings last quarter? Chemed Co. (NYSE:CHE) posted its quarterly earnings data on Wednesday, April, 24th. The company reported $4.68 earnings per share (EPS) for the quarter, missing the consensus estimate of $5.09 by $0.41. The company had revenue of $589.23 million for the quarter, compared to analyst estimates of $587.18 million. Chemed had a trailing twelve-month return on equity of 30.52% and a net margin of 12.36%. How often does Chemed pay dividends? What is the dividend yield for Chemed? Chemed announced a quarterly dividend on Monday, May 20th. Shareholders of record on Thursday, May 30th will be paid a dividend of $0.40 per share on Tuesday, June 18th. This represents a $1.60 annualized dividend and a dividend yield of 0.29%. The ex-dividend date is Thursday, May 30th. Read our dividend analysis for CHE. Is Chemed a good dividend stock? Chemed (NYSE:CHE) pays an annual dividend of $1.60 per share and currently has a dividend yield of 0.29%. The company has been increasing its dividend for 15 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 8.61%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CHE will have a dividend payout ratio of 6.67% next year. This indicates that the company will be able to sustain or increase its dividend. Read our dividend analysis for CHE. What ETFs hold Chemed's stock? ETFs with the largest weight of Chemed (NYSE:CHE) stock in their portfolio include Formidable Fortress ETF (KONG), VictoryShares THB Mid Cap ESG ETF (MDCP), Inspire Faithward Mid Cap Momentum ETF (GLRY), Opus Small Cap Value Plus ETF (OSCV), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), FIS Biblically Responsible Risk Managed ETF (PRAY), ProShares S&P MidCap 400 Dividend Aristocrats ETF (REGL) and SPDR S&P Health Care Services ETF (XHS). What guidance has Chemed issued on next quarter's earnings? Chemed issued an update on its FY 2024 earnings guidance on Wednesday, April, 24th. The company provided earnings per share (EPS) guidance of 23.300-23.700 for the period, compared to the consensus earnings per share estimate of 23.520. The company issued revenue guidance of -. What is Kevin J. McNamara's approval rating as Chemed's CEO? 1 employees have rated Chemed Chief Executive Officer Kevin J. McNamara on Glassdoor.com. Kevin J. McNamara has an approval rating of 100% among the company's employees. This puts Kevin J. McNamara in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Chemed own? Based on aggregate information from My MarketBeat watchlists, some companies that other Chemed investors own include AT&T (T), Home Depot (HD), Johnson & Johnson (JNJ), AbbVie (ABBV), Abbott Laboratories (ABT), CVS Health (CVS), Boeing (BA), UnitedHealth Group (UNH), Verizon Communications (VZ) and Chevron (CVX). Who are Chemed's major shareholders? Chemed's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Vanguard Group Inc. (11.24%), William Blair Investment Management LLC (3.06%), TD Asset Management Inc (1.68%), Epoch Investment Partners Inc. (1.21%), Acadian Asset Management LLC (1.19%) and TimesSquare Capital Management LLC (1.12%). Insiders that own company stock include Brian C Judkins, David Patrick Williams, Donald E Saunders, Kevin J Mcnamara, Michael D Witzeman, Nicholas Michael Westfall, Patrick P Grace, Spencer S Lee and Thomas P Rice. View institutional ownership trends. How do I buy shares of Chemed? Shares of CHE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NYSE:CHE) was last updated on 5/24/2024 by MarketBeat.com Staff From Our PartnersBiden replacement revealed?Paradigm PressThis could mean the end of the U.S dollar…Colonial MetalsUrgent Nvidia WarningAltimetryGold Set to EXPLODE!Gold Safe ExchangeWrite this ticker symbol down…StocksToTrade**Breaking News** LIttle Known Biotech Company Does $41 Million In Q1! Huge AlertsForget Bitcoin: This $8 Stock Is the Next Big ThingBehind the MarketsMost important medical advance in 100 yearsThe Oxford Club Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Chemed Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.